volume 115, issue 6, P1616-1626 2005
DOI: 10.1172/jci24480
View full text
Sign up to set email alerts

Abstract: T cell differentiation is a progressive process characterized by phenotypic and functional changes. By transferring tumor-specific CD8 + T cells into tumor-bearing mice at various stages of differentiation, we evaluated their efficacy for adoptive immunotherapy. We found that administration of naive and early effector T cells, in combination with active immunization and IL-2, resulted in the eradication of large, established tumors. Despite enhanced in vitro antitumor properties, more-differentiated effector …

Expand abstract